Market Tracker

02/12 5:45pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.90
Delayed Data
As of Feb 12
 +0.02 / +2.27%
Today’s Change
0.84
Today|||52-Week Range
1.66
-23.08%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close0.88
Today’s open0.90
Day’s range0.85 - 0.91
Volume624,934
Average volume (3 months)1,043,310
Market cap$202.1M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-36.36%
Earnings growth (this year)+4.44%
Earnings growth (next 5 years)--
Revenue growth (last year)+19.55%
P/E ratioNM
Price/Sales8.93
Price/Book2.88

Competitors

 Today’s
change
Today’s
% change
EGLTEgalet Corp-0.04-0.50%
IDRAIdera Pharmaceutical...-0.02-1.19%
CARACara Therapeutics In...+0.25+3.47%
--Innovative Pharmaceu...-0.01-3.62%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 4, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$26.8M
Annual profit (last year)-$50.4M
Net profit margin-188.04%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts